-
China's pharmaceutical circulation industry is showing four development trends
Time of Update: 2020-02-11
In addition, in the face of the fierce competition of the third-party logistics platform, downstream customers' demands for cost and efficiency and management improvement, the trend of pharmaceutical supply chain innovation in 2020 will continue to progress.
-
In order to restore the normal production of animal husbandry as soon as possible, the state has held five consecutive meetings a week, emphasizing the resumption of work, transportation
Time of Update: 2020-02-10
OA_show('918'); 1
Standing committee meeting of the Political Bureau of the CPC Central Committee: in order to maintain the normal production and marketing order
-
Statement of medical insurance bureau: squeeze circulation expenses and regulate dealers
Time of Update: 2020-01-19
In the answer to the reporter's questions, the state health insurance bureau also said that under the decentralized procurement mode, some enterprises do not pay attention to product innovation, quality and cost control, and excessively rely on sales channels.
-
Statement of medical insurance bureau: squeeze circulation expenses and regulate dealers
Time of Update: 2020-01-19
On January 17, the state health insurance bureau issued the second batch of national organization drug centralized purchase and use work answer questions (hereinafter referred
-
The second batch of state procurement latest notice issued
Time of Update: 2020-01-17
On the afternoon of January 17, the results of purchasing the second batch of national drugs with quantity can be seen! On the evening of the 16th, the state health insurance
-
From the change of bidding rules to see the attitude of the supervisor to the national centralized mining
Time of Update: 2020-01-16
Compared with the previous two times, the rules of this bidding have great changes: the number of shortlisted enterprises, division of supply areas, procurement cycle, etc., each of which will have a great impact on the bidding of related enterprises.
-
Breaking the fatal "drug shortage" and expanding the production base to 6
Time of Update: 2020-01-09
January 9, medical network news: "since the release of drug price control in China, there has been a shortage of drugs
This phenomenon is becoming more and more serious
-
Beware of Monopoly! Pay attention to drug price behavior
Time of Update: 2019-11-11
Manchester United striker The pharmaceutical industry has always been the focus of anti-monopoly law enforcement
In the first half of this year, according to relevant
-
Liaoning Province: 17 drugs investigated
Time of Update: 2019-10-24
On October 23, the centralized purchase network of drugs and medical consumables of Liaoning Province released the notice on investigation on the supply of drugs not according
-
With the deep globalization of the pharmaceutical industry, can the top position of the United States remain evergreen
Time of Update: 2019-08-09
To describe the current world drug R & D pattern with a paragraph is very vivid: the United States is the leader; Japan and the European Union run side by side; Japan's leading
-
The government attaches great importance to the unreasonable phenomenon of the rising price of commonly used drugs
Time of Update: 2019-04-09
[China Pharmaceutical network industry trends] the government said that it is normal for drug prices to rise and fall within a reasonable range, but if there is a significant rise
-
Two API companies were fined 12.43 million yuan for monopolizing
Time of Update: 2019-01-03
[China Pharmaceutical network industry news] recently, the State Administration of Market Supervision issued a news that the monopoly of chlorpheniramine API enterprises was punished by 12.43 million yuan according to law.
-
Led by the national health and Health Commission, another heavy catalog will be published this year
Time of Update: 2019-01-02
Notice on printing and distributing the work plan for accelerating the implementation of supply guarantee and use policy of generic drugs (gwsgf [2018] No
53) Health
-
Problems related to increasing attention to shortage of drugs in China are expected to be solved
Time of Update: 2018-10-16
[market analysis of chinapharma.com] to solve the problem of drug shortage, we should start from the production and supply of raw materials to the use of drugs
All links
-
The average decrease of anticancer drugs is 56.7%! All regions began to implement and link up one after another
Time of Update: 2018-10-13
According to the industry, the average decrease of payment standard of negotiated drugs is 56.7%, which will greatly reduce the drug burden of cancer patients in China.
-
The State Council will do it again, and the medical device industry will be revolutionized
Time of Update: 2018-05-25
As a result, the "separation of certificates and licenses", aiming at promoting innovative research and development and the reform of medical device registration system of specialized and large-scale production, has been approved to expand from Shanghai to Guangdong and Tianjin.
-
Jointly issued by four departments: 100 kinds of medicine in short supply will be produced centrally
Time of Update: 2018-02-02
Source: IGU February 2, 2018 Today (February 1), the Ministry of industry and information technology, together with the health and Family Planning Commission, the national
-
Yue bingfei: reduce the intermediate link and realize the high price of drugs
Time of Update: 2017-03-08
[expert opinion of chinapharma.com] on March 7, Yue bingfei, member of the CPPCC National Committee and researcher of China food and drug inspection and Research Institute, gave
-
The situation and challenges of new drug research and development in China in 2017
Time of Update: 2017-03-03
Source: innovation and development achievements of Bio Valley in 2017-3-3 During the "12th Five Year Plan" period, China's major new drug creation projects supported
-
Returning to the source of disease treatment the reform of drug field in China will be speeded up
Time of Update: 2017-01-26
[China Pharmaceutical network policies and regulations] a drug, from the initial production to the hands of patients, involves production, circulation, use and other links
